Penumbra Company Leadership
PEN Stock | USD 296.00 4.18 1.43% |
Penumbra's insiders are aggressively selling. The analysis of insiders' sentiment of trading Penumbra stock suggests that virtually all insiders are panicking at this time. Penumbra employs about 4.5 K people. The company is managed by 26 executives with a total tenure of roughly 103 years, averaging almost 3.0 years of service per executive, having 173.08 employees per reported executive.
Adam Elsesser Chairman Chairman of the Board, Chief Executive Officer |
James Pray President President International |
Insider Sentiment 0
Mostly Selling
Selling | Buying |
Latest Trades
2025-04-25 | Arani Bose | Disposed 12000 @ 298.73 | View | ||
2025-04-24 | Johanna Roberts | Disposed 600 @ 300.01 | View | ||
2025-04-16 | Adam Elsesser | Disposed 16560 @ 274.35 | View | ||
2025-04-15 | Bridget O'rourke | Disposed 50 @ 271.21 | View | ||
2025-04-02 | Thomas Wilder | Disposed 360 @ 266.93 | View | ||
2025-04-01 | Johanna Roberts | Disposed 600 @ 269.11 | View | ||
2025-03-31 | Thomas Wilder | Disposed 360 @ 264.58 | View | ||
2025-03-25 | Arani Bose | Disposed 12000 @ 283.77 | View | ||
2025-03-19 | Adam Elsesser | Disposed 16600 @ 276.21 | View | ||
2025-03-05 | Adam Elsesser | Disposed 61600 @ 283.59 | View | ||
2025-03-04 | Lambert Shiu | Disposed 501 @ 282.88 | View | ||
2025-03-03 | Maggie Yuen | Disposed 2000 @ 286 | View | ||
2025-01-03 | Harpreet Grewal | Disposed 167 @ 241.28 | View | ||
2024-12-20 | Adam Elsesser | Disposed 15000 @ 242.96 | View | ||
2024-12-02 | Johanna Roberts | Disposed 600 @ 244.49 | View | ||
2024-11-29 | Lambert Shiu | Disposed 1798 @ 242.56 | View |
Monitoring Penumbra's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Penumbra. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. Penumbra's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Penumbra's future performance. Based on our forecasts, it is anticipated that Penumbra will maintain a workforce of about 4500 employees by June 2025.Penumbra Management Team Effectiveness
The company has Return on Asset of 0.0582 % which means that on every $100 spent on assets, it made $0.0582 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.035 %, implying that it generated $0.035 on every 100 dollars invested. Penumbra's management efficiency ratios could be used to measure how well Penumbra manages its routine affairs as well as how well it operates its assets and liabilities. As of the 5th of May 2025, Return On Equity is likely to grow to 0.01, while Return On Tangible Assets are likely to drop 0.01. At this time, Penumbra's Non Current Assets Total are very stable compared to the past year. As of the 5th of May 2025, Non Currrent Assets Other is likely to grow to about 148.3 M, while Total Assets are likely to drop about 820.4 M.As of the 5th of May 2025, Common Stock Shares Outstanding is likely to drop to about 35.4 M. In addition to that, Net Loss is likely to grow to about (1.7 M)
Penumbra Workforce Comparison
Penumbra is regarded third in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 50,799. Penumbra holds roughly 4,500 in number of employees claiming about 9% of equities under Health Care industry.
Penumbra Profit Margins
The company has Net Profit Margin of 0.03 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.12 %, which entails that for every 100 dollars of revenue, it generated $0.12 of operating income.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.72 | 0.632 |
|
|
Penumbra Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Penumbra insiders, such as employees or executives, is commonly permitted as long as it does not rely on Penumbra's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Penumbra insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2025-06-01 | 0.1111 | 4 | 36 | 70,484 | 105,613 |
2025-03-01 | 0.2676 | 19 | 71 | 128,775 | 230,355 |
2024-12-01 | 0.1136 | 5 | 44 | 16,030 | 59,023 |
2024-03-01 | 0.7333 | 11 | 15 | 15,465 | 14,744 |
2023-12-01 | 0.0682 | 3 | 44 | 14,870 | 41,596 |
2023-09-01 | 0.0667 | 3 | 45 | 28,998 | 61,755 |
2023-06-01 | 0.0889 | 4 | 45 | 20,584 | 54,819 |
2023-03-01 | 0.32 | 8 | 25 | 5,360 | 34,504 |
2022-12-01 | 0.2692 | 7 | 26 | 25,830 | 16,773 |
2022-09-01 | 0.2 | 2 | 10 | 7,500 | 22,951 |
2022-06-01 | 0.2 | 2 | 10 | 3,500 | 7,156 |
2022-03-01 | 0.2368 | 9 | 38 | 23,510 | 39,308 |
2021-12-01 | 0.1528 | 11 | 72 | 69,350 | 124,224 |
2021-09-01 | 0.0811 | 6 | 74 | 44,600 | 102,723 |
2021-06-01 | 1.0 | 2 | 2 | 12,315 | 11,752 |
2021-03-01 | 0.1714 | 6 | 35 | 3,210 | 30,748 |
2020-12-01 | 0.0145 | 1 | 69 | 10,150 | 57,379 |
2020-09-01 | 0.0682 | 3 | 44 | 9,875 | 56,345 |
2020-03-01 | 0.1633 | 8 | 49 | 19,536 | 65,634 |
2019-12-01 | 0.0833 | 3 | 36 | 15,170 | 75,672 |
2019-09-01 | 0.0426 | 2 | 47 | 1,308 | 58,728 |
2019-06-01 | 0.0244 | 1 | 41 | 15,000 | 120,094 |
2019-03-01 | 0.4 | 6 | 15 | 5,756 | 69,904 |
2018-12-01 | 0.2143 | 3 | 14 | 6,439 | 13,404 |
2018-09-01 | 0.1778 | 8 | 45 | 34,426 | 161,758 |
2018-06-01 | 0.3333 | 4 | 12 | 10,237 | 106,149 |
2018-03-01 | 0.3333 | 10 | 30 | 72,506 | 148,300 |
2017-09-01 | 0.1333 | 2 | 15 | 35,188 | 107,033 |
2017-06-01 | 2.0 | 8 | 4 | 13,953 | 97,029 |
2017-03-01 | 0.1634 | 33 | 202 | 230,624 | 567,833 |
2016-12-01 | 1.0 | 3 | 3 | 34,668 | 29,537 |
2016-09-01 | 0.1842 | 28 | 152 | 400,000 | 907,999 |
2016-06-01 | 0.4286 | 3 | 7 | 4,651 | 40,500 |
2016-03-01 | 2.5 | 5 | 2 | 36,449 | 9,636 |
2015-09-01 | 0.6122 | 30 | 49 | 2,216,143 | 2,481,196 |
2015-06-01 | 0.6667 | 4 | 6 | 758,000 | 890,644 |
Penumbra Notable Stakeholders
A Penumbra stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Penumbra often face trade-offs trying to please all of them. Penumbra's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Penumbra's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Adam Elsesser | Chairman of the Board, Chief Executive Officer | Profile | |
Adam JD | Chairman, CoFounder | Profile | |
James Pray | President International | Profile | |
Gita Barry | President Healthcare | Profile | |
Lynn Rothman | Executive Vice President, Chief Business Officer | Profile | |
Johanna Roberts | Executive Vice President General Counsel, Secretary | Profile | |
Sandra Lesenfants | President Interventional | Profile | |
Maggie Yuen | Chief Financial Officer | Profile | |
Surbhi Sarna | Independent Director | Profile | |
Bridget ORourke | Independent Director | Profile | |
Holly Sit | Director Development | Profile | |
Harpreet Grewal | Independent Director | Profile | |
Don Kassing | Presiding Independent Director | Profile | |
Thomas Wilder | Independent Director | Profile | |
Arani Bose | Executive Director and Chief Innovator | Profile | |
Janet Leeds | Lead Independent Director | Profile | |
Johanna JD | General VP | Profile | |
Ben Tompkins | Executive Development | Profile | |
Shruthi Narayan | Executive Interventional | Profile | |
Arani MD | CoFounder Director | Profile | |
Pankaj Tiwari | Executive Officer | Profile | |
Jee HamlynHarris | Investor Officer | Profile | |
Ben Sorci | Executive Operations | Profile | |
Lambert Shiu | Chief Accounting Officer | Profile | |
MD FSIR | Chief Officer | Profile | |
Jason Mills | Executive Strategy | Profile |
About Penumbra Management Performance
The success or failure of an entity such as Penumbra often depends on how effective the management is. Penumbra management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Penumbra management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Penumbra management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.01 | 0.01 | |
Return On Capital Employed | 0.01 | 0.01 | |
Return On Assets | 0.01 | 0.01 | |
Return On Equity | 0.01 | 0.01 |
Penumbra Workforce Analysis
Traditionally, organizations such as Penumbra use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Penumbra within its industry.Penumbra Manpower Efficiency
Return on Penumbra Manpower
Revenue Per Employee | 265.5K | |
Revenue Per Executive | 45.9M | |
Net Income Per Employee | 3.1K | |
Net Income Per Executive | 538.9K | |
Working Capital Per Employee | 176.2K | |
Working Capital Per Executive | 30.5M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Penumbra. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Penumbra Stock, please use our How to Invest in Penumbra guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Penumbra. If investors know Penumbra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Penumbra listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.571 | Earnings Share 1.07 | Revenue Per Share | Quarterly Revenue Growth 0.163 | Return On Assets |
The market value of Penumbra is measured differently than its book value, which is the value of Penumbra that is recorded on the company's balance sheet. Investors also form their own opinion of Penumbra's value that differs from its market value or its book value, called intrinsic value, which is Penumbra's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Penumbra's market value can be influenced by many factors that don't directly affect Penumbra's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Penumbra's value and its price as these two are different measures arrived at by different means. Investors typically determine if Penumbra is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Penumbra's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.